Journal
MOLECULAR NUTRITION & FOOD RESEARCH
Volume 60, Issue 1, Pages 67-78Publisher
WILEY
DOI: 10.1002/mnfr.201500153
Keywords
Adipose Tissue; Diabetes; Dietary inorganic nitrate; Metabolism; Metabolic disease; Nitric oxide; Obesity
Categories
Funding
- MRC PhD studentship through MRC-Human Nutrition Research unit, Cambridge
- MRC-HNR Elsie Widdowson Fellowship
- BBSRC [Bb/H013539/2, bb/I000933/I]
- Wellcome Trust [093148/Z/10/Z]
- British Heart Foundation
- MRC (Lipid Profiling and Signalling programme grant) [UD99999906]
- BBSRC [BB/H013539/2] Funding Source: UKRI
- MRC [MC_UP_A090_1006, MR/P011705/1] Funding Source: UKRI
- Biotechnology and Biological Sciences Research Council [BB/H013539/2] Funding Source: researchfish
- Medical Research Council [MC_UP_A090_1006, MR/P011705/1] Funding Source: researchfish
Ask authors/readers for more resources
Historically, inorganic nitrate was believed to be an inert by-product of nitric oxide (NO) metabolism that was readily excreted by the body. Studies utilising doses of nitrate far in excess of dietary and physiological sources reported potentially toxic and carcinogenic effects of the anion. However, nitrate is a significant component of our diets, with the majority of the anion coming from green leafy vegetables, which have been consistently shown to offer protection against obesity, type 2 diabetes and metabolic diseases. The discovery of a metabolic pathway in mammals, in which nitrate is reduced to NO, via nitrite, has warranted a re-examination of the physiological role of this small molecule. Obesity, type 2 diabetes and the metabolic syndrome are associated with a decrease in NO bioavailability. Recent research suggests that the nitrate-nitrite-NO pathway may be harnessed as a therapeutic to supplement circulating NO concentrations, with both anti-obesity and anti-diabetic effects, as well as improving vascular function. In this review, we examine the key studies that have led to the re-evaluation of the physiological function of inorganic nitrate, from toxic and carcinogenic metabolite, to a potentially important and beneficial agent in the treatment of metabolic disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available